Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC
{{output}}
Introduction: Co-occurring mutations in KRAS-mutant NSCLC are associated with discrete biological properties and modulate therapeutic susceptibilities. As G12D-specific inhibitors are expected to enter the clinic, we sought to in... ...
